European equity markets, initially poised for a subdued start on Friday, found upward momentum as the trading session commenced, buoyed by a rally in healthcare shares and renewed optimism surrounding US-China trade relations.
Investors, however, remained watchful, balancing the positive sentiment with ongoing global trade tensions and awaiting key regional economic data.
In premarket indications, Euro Stoxx 50 and Stoxx 600 futures had hinted at a flat to slightly positive open. Yet, as trading got underway, European shares extended their gains.
The pan-European STOXX 600 index advanced 0.4% by 0710 GMT, positioning itself for a fifth consecutive weekly rise.
This positive trajectory was mirrored across other local bourses, with Germany’s DAX notably trading near record high levels.
The heavyweight healthcare sub-index was a significant driver, climbing 1.4%, propelled by strong performances from pharmaceutical giants Novo Nordisk and Novartis.
The improved risk appetite was largely attributed to benign headlines suggesting a temporary truce in US-China trade disputes.
EU’s confident stance and key economic releases
The intricate dance of international trade remains a central theme for market participants.
European Union officials reiterated on Thursday that the bloc is actively pursuing a more comprehensive tariff reduction agreement with the United States, one that goes beyond the scope of current negotiations with the UK and China.
EU negotiators have expressed confidence in the bloc’s economic leverage, signaling a firm stance against being pressured into unfavorable terms.
On the economic data front, investor attention is keenly focused on the upcoming release of the Eurozone trade balance figures for March.
Additionally, Italy’s latest inflation rate and France’s unemployment data are anticipated, which could provide further insights into the region’s economic health.
With a light schedule for major corporate earnings, these macroeconomic developments and evolving trade narratives are expected to be primary drivers of market sentiment.
ECB navigates inflation
Adding another layer to the market calculus, commentary from European Central Bank officials suggests a potential nearing of the peak in its interest rate cycle.
Governing Council member Martins Kazaks told CNBC that the ECB’s interest rates are “relatively close to the terminal rate” if inflation continues to track within the central bank’s expectations.
“Currently, if one takes a look at the dynamics of inflation, we are by and large within the baseline scenario and if the baseline scenario holds, then I think we are relatively close to the terminal rate already,” stated Kazaks, who also serves as the Latvian central bank governor, speaking to CNBC’s Silvia Amaro on ‘Europe Early Edition’.
The terminal rate signifies the point at which interest rates neither hinder nor overly stimulate economic growth, allowing the central bank to achieve its inflation target.
The ECB’s key deposit facility rate currently stands at 2.25%, following a unanimous decision by the governing council to implement a 25 basis point reduction in April.
Kazaks also indicated that market expectations for a further 25 basis point cut at the ECB’s next policy meeting on June 5 are “relatively appropriate, in my view..
This view aligns with remarks made by fellow ECB board member Isabel Schnabel last week, who said: “The appropriate course of action is to keep rates close to where they are today – that is, firmly in neutral territory.”
While investment banks offer slightly varied outlooks, with Goldman Sachs anticipating two rate cuts this year and JPMorgan forecasting one, the overarching sentiment from within the ECB points towards a cautious approach as it navigates the path towards its inflation goals.
The post Europe markets open: STOXX 600 rises 0.4% on trade hopes, ECB signals rate peak appeared first on Invezz